Connect Biopharma Holdings LTD (CNTB) — 6-K Filings

6-K Filings (7)

• Connect Biopharma Files March 2025 6-K Report — Mar 28, 2025 Risk: low
  Connect Biopharma Holdings Ltd. filed a Form 6-K on March 28, 2025, reporting information for the month of March 2025. The company is a foreign private issuer a
• Connect Biopharma Files 6-K Report — Dec 23, 2024 Risk: low
  Connect Biopharma Holdings Limited filed a Form 6-K on December 23, 2024, reporting for the month of December 2024. The filing is a report of a foreign private
• Connect Biopharma Files 6-K for September 2024 — Sep 6, 2024 Risk: low
  Connect Biopharma Holdings Limited filed a Form 6-K on September 6, 2024, to report its activities for the month of September 2024. The filing indicates that th
• Connect Biopharma Files 6-K with Mid-Year Financials — Sep 5, 2024 Risk: low
  Connect Biopharma Holdings Ltd filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the six months ended June 30, 2024
• Connect Biopharma Files 6-K, Reports Foreign Issuer Status — Aug 2, 2024 Risk: low
  Connect Biopharma Holdings Limited filed a Form 6-K on August 2, 2024, reporting its status as a foreign private issuer. The filing indicates the company is sub
• Connect Biopharma Files June 2024 6-K Report — Jun 12, 2024 Risk: low
  Connect Biopharma Holdings Limited filed a Form 6-K on June 12, 2024, reporting its activities for the month of June 2024. The company, incorporated in E9 with
• Connect Biopharma Appoints Biotech Veteran James Huang to Board — Feb 12, 2024 Risk: low
  Connect Biopharma Holdings Limited announced on February 12, 2024, the immediate appointment of James Zuie-chin Huang, M.B.A., to its Board of Directors. Mr. Hu

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX